NRx Pharmaceuticals (NRXP) News Today $3.15 -0.05 (-1.56%) Closing price 04:00 PM EasternExtended Trading$3.12 -0.02 (-0.79%) As of 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NRXP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Financial Comparison: Mangoceuticals (NASDAQ:MGRX) & NRx Pharmaceuticals (NASDAQ:NRXP)October 24 at 2:25 AM | americanbankingnews.comNRx Pharmaceuticals' (NRXP) Buy Rating Reaffirmed at D. Boral CapitalOctober 21 at 8:18 AM | marketbeat.comNRx Pharmaceuticals, HOPE Therapeutics announces Cohen & Associates inclusionOctober 20, 2025 | msn.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr ...October 20, 2025 | markets.businessinsider.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical DirectorOctober 20, 2025 | globenewswire.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Consensus Rating of "Moderate Buy" from BrokeragesOctober 19, 2025 | americanbankingnews.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Given Consensus Rating of "Moderate Buy" by AnalystsOctober 19, 2025 | marketbeat.comNRx Pharmaceuticals (NRXP) Pursues Dual Pathway for Preservative-Free Ketamine-Based TherapiesOctober 17, 2025 | finance.yahoo.comNRx Pharmaceuticals (NASDAQ:NRXP) Shares Down 4.1% - Here's WhyOctober 17, 2025 | marketbeat.comNRx Pharmaceuticals' (NRXP) "Buy" Rating Reaffirmed at HC WainwrightOctober 16, 2025 | marketbeat.comWeiss Ratings Reaffirms "Sell (D-)" Rating for NRx Pharmaceuticals (NASDAQ:NRXP)October 10, 2025 | marketbeat.comNRx Pharmaceuticals (NRXP) Strengthens Pipeline With Dual Pathways for Ketamine-Based TherapiesOctober 10, 2025 | finance.yahoo.comNRx Pharmaceuticals (NASDAQ: NRXP) Strengthens Pipeline with Dual Pathways for Ketamine-Based TherapiesOctober 10, 2025 | msn.comNRx Pharmaceuticals (NRXP) to Present at Noble Capital Markets Emerging Growth Virtual Equity ConferenceOctober 7, 2025 | finance.yahoo.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity ConferenceOctober 6, 2025 | markets.businessinsider.comNRx Pharmaceuticals and HOPE Therapeutics to Present at Noble Capital Markets Emerging Growth Virtual Equity ConferenceOctober 6, 2025 | quiverquant.comQNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity ConferenceOctober 6, 2025 | globenewswire.comNRx Pharmaceuticals (NRXP) Re-files ANDA for Preservative-Free IV Ketamine KETAFREE(TM)October 1, 2025 | finance.yahoo.comNRx Pharmaceuticals' (NRXP) Buy Rating Reiterated at HC WainwrightOctober 1, 2025 | marketbeat.comNRx Pharmaceuticals Refiles ANDA for KETAFREE™, a Preservative-Free IV Ketamine Formulation Amid Drug ShortageSeptember 29, 2025 | quiverquant.comQNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Re-Files Abbreviated New Drug Application (ANDA) for KETAFREE™, Preservative-Free IV KetamineSeptember 29, 2025 | globenewswire.comNRX Pharmaceuticals Gains FDA Approval for KETAFREE™September 26, 2025 | msn.comD. Boral Capital Maintains NRx Pharmaceuticals (NRXP) Buy RecommendationSeptember 25, 2025 | msn.comNRx Pharmaceuticals (NASDAQ:NRXP) Given Buy Rating at D. Boral CapitalSeptember 25, 2025 | marketbeat.comNRx Pharmaceuticals (NRXP) Receives FDA Approval of Suitability Petition for Preservative-Free Ketamine ProductSeptember 25, 2025 | finance.yahoo.comNRX Pharmaceuticals stock surges after FDA grants Suitability PetitionSeptember 24, 2025 | za.investing.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx’s Proposed Strength of Preservative ...September 24, 2025 | finance.yahoo.comNew to The Street's Prestigious Client NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength...September 24, 2025 | markets.businessinsider.comNRx Pharmaceuticals Receives FDA Approval for Suitability Petition for KETAFREE™, Enabling Re-filing of ANDA for Preservative-Free KetamineSeptember 24, 2025 | quiverquant.comQNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx's Proposed Strength of Preservative-Free KetamineSeptember 24, 2025 | globenewswire.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Given Average Recommendation of "Buy" by AnalystsSeptember 24, 2025 | marketbeat.comNRx Pharmaceuticals (NASDAQ:NRXP) Rating Increased to Hold at Zacks ResearchSeptember 14, 2025 | marketbeat.comFY2025 Earnings Forecast for NRXP Issued By HC WainwrightSeptember 13, 2025 | marketbeat.comAnson Funds Management LP Buys 993,401 Shares of NRx Pharmaceuticals, Inc. $NRXPSeptember 13, 2025 | marketbeat.comResearch Analysts Set Expectations for NRXP Q3 EarningsSeptember 12, 2025 | marketbeat.comNRx Pharmaceuticals (NASDAQ:NRXP) Receives Buy Rating from D. Boral CapitalSeptember 10, 2025 | marketbeat.comNRx Pharmaceuticals (NASDAQ:NRXP) Given "Buy" Rating at HC WainwrightSeptember 10, 2025 | marketbeat.comNRx Pharmaceuticals (NRXP) Subsidiary HOPE Therapeutics Closes Acquisition of Dura MedicalSeptember 9, 2025 | finance.yahoo.comNRx Pharmaceuticals initiated with a Buy at H.C. WainwrightSeptember 8, 2025 | msn.comNRX Pharmaceuticals Raises $8.8 Million in Stock OfferingSeptember 8, 2025 | msn.comHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry ClinicsSeptember 8, 2025 | globenewswire.comNRx Pharmaceuticals (NASDAQ: NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal DepressionSeptember 3, 2025 | msn.comNRx Pharmaceuticals presents two keynote talks at 2025 Global Passion ProjectSeptember 3, 2025 | theglobeandmail.comNRx Pharmaceuticals’ Earnings Call Highlights Strategic ProgressSeptember 3, 2025 | theglobeandmail.comNRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8thSeptember 3, 2025 | finance.yahoo.comNRx Pharmaceuticals (NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal DepressionSeptember 3, 2025 | finance.yahoo.comNRx Pharmaceuticals (NASDAQ:NRXP) to Participate in a Fireside Chat at H.C. Wainwright's 27th Annual Global Investment Conference on Monday, September 8thSeptember 3, 2025 | globenewswire.comUPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller, Sponsored by Rockefeller Global Family OfficeSeptember 2, 2025 | globenewswire.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller CapitalSeptember 2, 2025 | finance.yahoo.comNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller CapitalSeptember 2, 2025 | globenewswire.com Get NRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NRXP Media Mentions By Week NRXP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NRXP News Sentiment▼0.450.63▲Average Medical News Sentiment NRXP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NRXP Articles This Week▼84▲NRXP Articles Average Week Get the Latest News and Ratings for NRXP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for NRx Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Lunai Bioworks News Sagimet Biosciences News Atea Pharmaceuticals News Maxpro Capital Acquisition News Humacyte News Lifecore Biomedical News Cartesian Therapeutics News Adherex Technologies News Tiziana Life Sciences News Enanta Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NRXP) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredTrade this between 9:30 and 10:45 am ESTIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredBitcoin is dead?Bitcoin’s historic run may be ending — and Weiss Ratings’ Juan Villaverde, who’s nailed every major crypto bul...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NRXP Stock Alerts